Brian McClune

3.1k total citations
68 papers, 998 citations indexed

About

Brian McClune is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Brian McClune has authored 68 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 40 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Brian McClune's work include Multiple Myeloma Research and Treatments (38 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Acute Myeloid Leukemia Research (12 papers). Brian McClune is often cited by papers focused on Multiple Myeloma Research and Treatments (38 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Acute Myeloid Leukemia Research (12 papers). Brian McClune collaborates with scholars based in United States, Canada and Australia. Brian McClune's co-authors include Daniel J. Weisdorf, Navneet S. Majhail, Ghulam Rehman Mohyuddin, John F. DiPersio, Gisela Tunes da Silva, Tanya L. Pedersen, Martin S. Tallman, Jorge Sierra, Armand Keating and Theresa Hahn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Brian McClune

58 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian McClune United States 15 750 323 278 213 144 68 998
Waleska S. Pérez United States 17 1.3k 1.7× 354 1.1× 549 2.0× 215 1.0× 182 1.3× 27 1.5k
Wolfram Pönisch Germany 15 806 1.1× 243 0.8× 220 0.8× 198 0.9× 218 1.5× 62 1.0k
Seung‐Hwan Shin South Korea 18 570 0.8× 205 0.6× 169 0.6× 162 0.8× 133 0.9× 68 777
Marie‐Christiane Vekemans Belgium 14 456 0.6× 195 0.6× 206 0.7× 255 1.2× 44 0.3× 40 838
Jean Paul Vernant France 13 665 0.9× 191 0.6× 311 1.1× 148 0.7× 122 0.8× 25 863
Ann E. Hunter United Kingdom 12 964 1.3× 459 1.4× 311 1.1× 388 1.8× 142 1.0× 20 1.3k
Annie Im United States 13 403 0.5× 301 0.9× 116 0.4× 242 1.1× 231 1.6× 64 851
Asmita Mishra United States 15 411 0.5× 234 0.7× 87 0.3× 187 0.9× 72 0.5× 63 672
Eros Di Bona Italy 17 835 1.1× 169 0.5× 431 1.6× 394 1.8× 68 0.5× 46 1.1k
Marino Clavio Italy 22 841 1.1× 457 1.4× 280 1.0× 270 1.3× 336 2.3× 79 1.3k

Countries citing papers authored by Brian McClune

Since Specialization
Citations

This map shows the geographic impact of Brian McClune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian McClune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian McClune more than expected).

Fields of papers citing papers by Brian McClune

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian McClune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian McClune. The network helps show where Brian McClune may publish in the future.

Co-authorship network of co-authors of Brian McClune

This figure shows the co-authorship network connecting the top 25 collaborators of Brian McClune. A scholar is included among the top collaborators of Brian McClune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian McClune. Brian McClune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohyuddin, Ghulam Rehman, Rajshekhar Chakraborty, Douglas W. Sborov, et al.. (2025). Patient Preferences on Clinical Decision Making in Multiple Myeloma. JCO Oncology Practice. OP2500322–OP2500322.
2.
Baysal, Mehmet, Douglas W. Sborov, Amandeep Godara, et al.. (2025). The past, present, and future of myeloma staging and risk prognostication. The Oncologist. 30(10).
3.
Chakraborty, Rajshekhar, Al‐Ola Abdallah, Suzanne Lentzsch, et al.. (2024). Spotlight: Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial. Blood. 144(Supplement 1). 6924–6924.
4.
5.
Tantravahi, Srinivas K., Benjamin Haaland, Brian McClune, et al.. (2022). Impact of academic medical center access on outcomes in multiple myeloma. American Journal of Hematology. 98(1). 41–48. 7 indexed citations
6.
Sborov, Douglas W., Brian McClune, Vinay Prasad, et al.. (2022). Time‐to‐event surrogate end‐points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis. British Journal of Haematology. 200(5). 587–594. 10 indexed citations
7.
Singleton, Michael, et al.. (2022). Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population. Cell Transplantation. 31. 4221138241–4221138241. 2 indexed citations
8.
Abdallah, Al‐Ola, Nausheen Ahmed, Leyla Shune, et al.. (2022). Palliative care utilization, transfusion burden, and end‐of‐life care for patients with multiple myeloma. European Journal Of Haematology. 109(5). 559–565. 6 indexed citations
9.
Banerjee, Rahul, Aakash Desai, Muhammad Aziz, et al.. (2022). Financial toxicity in hematological malignancies: a systematic review. Blood Cancer Journal. 12(4). 74–74. 33 indexed citations
10.
Abbasi, Saqib, Kathan Mehta, Brian McClune, et al.. (2022). Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma. SHILAP Revista de lepidopterología. 4(1-2). 56–59. 1 indexed citations
11.
Mohyuddin, Ghulam Rehman, et al.. (2022). A survey on the patient perspective on cure in multiple myeloma. The Lancet Haematology. 9(10). e716–e719. 1 indexed citations
12.
Mohyuddin, Ghulam Rehman, et al.. (2021). Chimeric antigen receptor T-cell therapy in multiple myeloma: a systematic review and meta-analysis of 950 patients. Blood Advances. 5(4). 1097–1101. 20 indexed citations
13.
Mohyuddin, Ghulam Rehman, Al‐Ola Abdallah, Douglas W. Sborov, et al.. (2021). Use of endpoints in multiple myeloma randomized controlled trials over the last 15 years: A systematic review. American Journal of Hematology. 96(6). 690–697. 17 indexed citations
14.
Mohyuddin, Ghulam Rehman, Nausheen Ahmed, Douglas W. Sborov, et al.. (2021). Intention to treat versus modified intention-to-treat analysis in B-cell maturation antigen and CD19 chimeric antigen receptor trials: A systematic review and meta-analysis. European Journal of Cancer. 156. 164–174. 10 indexed citations
15.
Mohyuddin, Ghulam Rehman, et al.. (2020). A Critical Appraisal and Targeted Intervention of the Oncology Experience in an Internal Medicine Residency. Journal of Cancer Education. 36(6). 1290–1294. 1 indexed citations
16.
Mohyuddin, Ghulam Rehman, Saqib Abbasi, Brian McClune, et al.. (2020). Inpatient mortality of patients with multiple myeloma and renal impairment undergoing autologous stem cell transplantation. European Journal Of Haematology. 105(5). 571–577. 2 indexed citations
17.
Mohyuddin, Ghulam Rehman, Brian McClune, Anurag K. Singh, et al.. (2020). Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation. Leukemia Research. 95. 106402–106402. 17 indexed citations
18.
Mohyuddin, Ghulam Rehman, Muhammad Aziz, Brian McClune, Al‐Ola Abdallah, & Muzaffar H. Qazilbash. (2019). Antibiotic prophylaxis for patients with newly diagnosed multiple myeloma: Systematic review and meta‐analysis. European Journal Of Haematology. 104(5). 420–426. 13 indexed citations
19.
Hegerova, Livia, Qing Cao, Aleksandr Lazaryan, et al.. (2017). Improving outcomes after allogeneic hematopoietic cell transplantation for Hodgkin lymphoma in the brentuximab vedotin era. Bone Marrow Transplantation. 52(5). 697–703. 7 indexed citations
20.
McClune, Brian, Daniel J. Weisdorf, Tanya L. Pedersen, et al.. (2010). Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome. Journal of Clinical Oncology. 28(11). 1878–1887. 338 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Waleska S. Pérez Breakdown of academic impact, for papers by Wolfram Pönisch Breakdown of academic impact, for papers by Seung‐Hwan Shin Breakdown of academic impact, for papers by Marie‐Christiane Vekemans Breakdown of academic impact, for papers by Jean Paul Vernant Breakdown of academic impact, for papers by Ann E. Hunter Breakdown of academic impact, for papers by Annie Im Breakdown of academic impact, for papers by Asmita Mishra Breakdown of academic impact, for papers by Eros Di Bona Breakdown of academic impact, for papers by Marino Clavio
Rankless by CCL
2026